Alcon Ag Stock Performance
| ALC Stock | USD 80.76 0.15 0.19% |
Alcon AG has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.1, which signifies a somewhat significant risk relative to the market. Alcon AG returns are very sensitive to returns on the market. As the market goes up or down, Alcon AG is expected to follow. Alcon AG right now shows a risk of 1.38%. Please confirm Alcon AG information ratio, treynor ratio, and the relationship between the downside deviation and total risk alpha , to decide if Alcon AG will be following its price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alcon AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Alcon AG may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Actual Historical Performance (%)
One Day Return 0.53 | Five Day Return 2.47 | Year To Date Return 5.19 | Ten Year Return 39.63 | All Time Return 39.63 |
Forward Dividend Yield 0.0034 | Payout Ratio 0.1855 | Forward Dividend Rate 0.27 | Dividend Date 2024-05-16 | Ex Dividend Date 2024-05-10 |
1 | Wall Streets Insights Into Key Metrics Ahead of Alcon Q4 Earnings | 02/22/2024 |
2 | Alcon Inc. Q4 2023 Earnings Call Transcript | 02/29/2024 |
3 | Alcon introduces advanced Clareon IOLs in India | 03/12/2024 |
4 | Cataract Market Set to Soar by 2032 Forecasts by DelveInsight Allergan, Merck, Pfizer, Teva Pharma, Bayer, Novartis, | 03/25/2024 |
5 | Global Intraocular Lens Market Expected to Reach USD 9.82 Billion by 2034 | 03/27/2024 |
6 | Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 2 Clinical Trial | 03/28/2024 |
7 | Aurion Biotech to Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting | 04/02/2024 |
8 | Heres Why Investors Should Buy Alcon Stock Right Now | 04/03/2024 |
9 | Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54 percent in the US by 2034 DelveInsight | 04/09/2024 |
10 | Ocular Therapeutix Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO | 04/15/2024 |
11 | Global Vision Care Market Projected to Surpass US 102 Billion by 2030 as Demand for Advanced Eye Care Solutions Grows | 04/19/2024 |
| Begin Period Cash Flow | 980.5 M |
Alcon |
Alcon AG Relative Risk vs. Return Landscape
If you would invest 7,630 in Alcon AG on January 25, 2024 and sell it today you would earn a total of 446.00 from holding Alcon AG or generate 5.85% return on investment over 90 days. Alcon AG is generating 0.101% of daily returns assuming volatility of 1.3815% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Alcon, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Alcon AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alcon AG's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alcon AG, and traders can use it to determine the average amount a Alcon AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0731
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ALC | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.38 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Alcon AG is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alcon AG by adding it to a well-diversified portfolio.
Alcon AG Fundamentals Growth
Alcon Stock prices reflect investors' perceptions of the future prospects and financial health of Alcon AG, and Alcon AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Alcon Stock performance.
| Return On Equity | 0.0483 | ||||
| Return On Asset | 0.0217 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 43.8 B | ||||
| Shares Outstanding | 493.24 M | ||||
| Price To Earning | 62.60 X | ||||
| Price To Book | 1.94 X | ||||
| Price To Sales | 4.25 X | ||||
| Revenue | 10.09 B | ||||
| Gross Profit | 4.81 B | ||||
| EBITDA | 2.56 B | ||||
| Net Income | 1.04 B | ||||
| Cash And Equivalents | 1.03 B | ||||
| Cash Per Share | 2.10 X | ||||
| Total Debt | 5.14 B | ||||
| Debt To Equity | 0.22 % | ||||
| Current Ratio | 2.16 X | ||||
| Book Value Per Share | 41.81 X | ||||
| Cash Flow From Operations | 1.48 B | ||||
| Earnings Per Share | 1.96 X | ||||
| Market Capitalization | 39.76 B | ||||
| Total Asset | 29.6 B | ||||
| Retained Earnings | 28.5 M | ||||
| Working Capital | 3.17 B | ||||
| Current Asset | 33.24 M | ||||
| Current Liabilities | 182.23 M | ||||
About Alcon AG Performance
To evaluate Alcon AG Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Alcon AG generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Alcon Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Alcon AG market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Alcon's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 188.95 | 129.78 | |
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.05 | 0.05 |
Things to note about Alcon AG performance evaluation
Checking the ongoing alerts about Alcon AG for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alcon AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alcon AG is unlikely to experience financial distress in the next 2 years | |
| About 66.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Global Vision Care Market Projected to Surpass US 102 Billion by 2030 as Demand for Advanced Eye Care Solutions Grows |
- Analyzing Alcon AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alcon AG's stock is overvalued or undervalued compared to its peers.
- Examining Alcon AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alcon AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alcon AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alcon AG's stock. These opinions can provide insight into Alcon AG's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alcon AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Alcon Stock refer to our How to Trade Alcon Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Alcon Stock analysis
When running Alcon AG's price analysis, check to measure Alcon AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alcon AG is operating at the current time. Most of Alcon AG's value examination focuses on studying past and present price action to predict the probability of Alcon AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alcon AG's price. Additionally, you may evaluate how the addition of Alcon AG to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Alcon AG's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alcon AG. If investors know Alcon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alcon AG listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.783 | Dividend Share 0.285 | Earnings Share 1.96 | Revenue Per Share 19.178 | Quarterly Revenue Growth 0.083 |
The market value of Alcon AG is measured differently than its book value, which is the value of Alcon that is recorded on the company's balance sheet. Investors also form their own opinion of Alcon AG's value that differs from its market value or its book value, called intrinsic value, which is Alcon AG's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alcon AG's market value can be influenced by many factors that don't directly affect Alcon AG's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alcon AG's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alcon AG is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alcon AG's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.